Chapter 2 - ELLIE SAW HER OWN CHILDHOOD BRAIN SCAN ON A THIRTY-FOOT SCREEN, AND THE CEO CLAIMED HER MOTHER HAD GIVEN HIM PERMISSION
Fifteen years after a temporary security guard noticed a metallic reflection inside Ellie Westbrook’s left ear, Ellie sat in the fourth row of the largest biomedical engineering conference in Boston and watched a stranger sell her childhood to eight hundred investors.
She was twenty-three.
Her dark hair was cut shorter now, just above her shoulders. A pair of slim hearing devices rested behind her ears because she had chosen to wear them that morning.
By lunch, she would probably remove them.
Large conference halls were exhausting.
Too many microphones.
Too much echo.
Too many people who believed volume created clarity.
Ellie remained fluent in American Sign Language. She spoke when she wanted. Signed when she wanted. Used captions constantly. Her hearing devices were tools, not declarations about who she had become.
That morning she was attending the North American Biomedical Interface Summit as a junior engineer with the Independent Center for Accessible Technology.
Her mother had offered to reserve her a front-row seat.
Ellie had refused.
Naturally.
Claire Westbrook was somewhere three states away running a Westbrook Systems board meeting.
Logan Reed—now Claire’s husband—was at a disaster communications exercise in Virginia.
Ben Reed, twenty-two and finishing graduate school in infrastructure resilience, had texted Ellie before the keynote:
IF ANY CEO SAYS “REVOLUTIONARY” MORE THAN SIX TIMES, YOU OWE ME TEN DOLLARS.
Ellie replied:
YOU OWE ME FOR MAKING ME COUNT.
Then the lights dimmed.
A man stepped onto the stage.
Dr. Nathan Calder.
Forty-seven.
Founder and chief executive of Sonora Neurotech.
The conference program described him as a biomedical entrepreneur, former neural-interface researcher, and “one of the architects of the next generation of personalized auditory access.”
Ellie already disliked the phrase.
Not because auditory access was bad.
Because people who talked about disability as “next generation” often forgot disabled people were already living in the current one.
Calder smiled beneath the enormous screen.
“Today,” he began, “we are going to show you what happens when fifteen years of neglected acoustic-interface research is finally brought into the light.”
Ellie stopped taking notes.
Fifteen years.
Coincidence.
Probably.
Then the first slide appeared.
AURALINK S2 — ADAPTIVE BONE-ACOUSTIC INTERFACE
The device itself was external.
A small behind-the-ear unit coupled with a vibration pad near the mastoid.
Nothing implanted.
Good.
Ellie leaned forward.
The engineering was interesting.
Adaptive frequency filtering.
User-controlled sound profiles.
Automatic noise reduction.
Optional tactile cueing.
Some of it genuinely thoughtful.
Then Calder said:
“The foundation for this architecture goes back further than most people realize.”
Slide changed.
THE WESTBROOK PEDIATRIC CASE — 15-YEAR FOLLOW-UP
Ellie’s entire body went still.
No name.
But she knew.
On the screen was an imaging slice of a child’s left temporal bone.
A small silver-gray object sat deep beside the eardrum.
Her device.
The one surgically removed when she was eight.
The room disappeared.
She could not hear Calder anymore.
Not because her devices stopped working.
Because her mind did.
Her fingers went cold.
The next slide showed an old otoscopic image.
Then an audiogram.
Her audiogram.
She recognized the irregular frequency pattern because she had studied her own history enough times in college to understand exactly what it looked like.
Calder continued speaking.
Captions rolled beneath the screen.
This early pediatric case demonstrated that controlled vibration masking could alter apparent auditory thresholds for extended periods without permanent structural destruction.
Ellie stared.
Controlled vibration masking.
That was a polished way to describe what had happened to her.
A device inserted without lawful consent.
A hidden object that distorted testing.
Six years of medical records built on false information.
Calder’s next sentence made her stomach turn.
While the original research was ethically imperfect by modern standards, the physiological data became invaluable.
Ethically imperfect.
Ellie stood.
The woman beside her looked startled.
On stage, Calder continued.
“We have now inverted that principle. Instead of masking useful sound, Auralink amplifies access through controlled vibration and personalized acoustic pathways.”
Ellie walked toward the aisle.
Then stopped.
No.
Walking out would give Calder the room.
She turned.
A conference attendant noticed her.
Ellie signed, then spoke clearly enough:
“I need a microphone.”
The attendant blinked.
“Questions are after—”
“Now.”
Something in her face worked.
The attendant hesitated, then passed a wireless mic.
Calder noticed movement.
“Yes?”
Ellie lifted microphone.
The room quieted.
“My name is Ellie Westbrook.”
It took less than two seconds.
People recognized.
A few heads turned.
Someone gasped.
Calder’s smile vanished.
Ellie continued.
“The pediatric scan on your screen belongs to me.”
Silence.
She pointed.
“That image came from a surgery performed after an unauthorized experimental device was discovered in my ear when I was eight years old.”
Calder’s expression hardened into something professional.
“Ms. Westbrook, I would be happy to discuss—”
“No.”
Her voice carried.
The hearing devices made her own volume difficult to judge, but she did not care.
“You called what happened to me ‘ethically imperfect research.’”
Another.
“It was not research I consented to.”
Another.
“My mother did not consent to it.”
Another.
“The device was not in my medical record.”
The room became completely still.
Ellie signed as she spoke, partly from habit, partly because another deaf engineer two rows behind her was watching.
“Who gave your company permission to use my scan?”
Calder paused.
Then:
“We acquired historical research assets lawfully.”
“That was not my question.”
Someone in audience murmured.
Calder tried again.
“Our legal team reviewed the consent framework attached to the archive.”
Ellie’s chest tightened.
“What consent?”
Calder looked toward side stage.
A lawyer approached.
Wrong move.
Ellie’s eyes narrowed.
Calder finally said:
“Your mother’s.”
The room changed.
Ellie stopped breathing.
“Excuse me?”
“Our records contain a parental authorization executed by Claire Westbrook permitting de-identified medical and imaging data to be used for continuing research.”
“No.”
Calder’s face remained composed.
“I understand this may be surprising.”
“It is false.”
“We have a signed document.”
“No.”
Ellie knew her mother.
Claire had spent fifteen years doing the opposite.
She had created independent research governance.
Published old Westbrook failures.
Refused to let Ellie’s case become marketing.
She would not secretly sign away medical data.
Calder nodded toward screen technician.
A scanned document appeared.
PEDIATRIC PROCEDURE AND CONTINUING RESEARCH AUTHORIZATION
Patient:
ELLIE WESTBROOK
Guardian:
CLAIRE WESTBROOK
Date:
Three weeks before Ellie’s second birthday.
Below:
A signature.
Claire’s.
Ellie stared.
It looked real.
Very real.
The agreement granted broad permission to:
“collect, retain, analyze, transfer, license, and utilize clinical, imaging, auditory, and physiological data for current and future research purposes.”
It also referred to:
“experimental acoustic-interface technology.”
Ellie’s heart hammered.
That phrase had never appeared in the surgery consent Claire remembered.
Calder said quietly:
“We did not use your name until today.”
“You put Westbrook on the slide.”
“The research subsidiary was Westbrook-affiliated.”
“You knew who I was.”
“Yes.”
“Did you know the device was placed without documented consent?”
Calder paused too long.
“We knew there had been later controversy.”
Controversy.
Ellie almost laughed.
“My uncle and a surgeon were investigated for what happened.”
“I’m aware.”
“And you still built an investor presentation around it.”
“We built a medical technology around data.”
Ellie stared.
“Those are not the same thing.”
Applause erupted somewhere behind her.
Not huge.
Then larger.
Calder looked furious.
Ellie did not care.
She handed microphone back.
Then removed both hearing devices.
The room became quieter.
Not silent.
Never entirely.
But manageable.
She turned and walked out.
---
Her phone vibrated before she reached hallway.
Claire.
Of course.
Someone had already sent video.
Ellie answered video call.
Claire’s face filled screen.
She was in a conference room.
“Are you okay?”
Ellie signed first.
YES. ANGRY.
Claire signed back.
I SAW.
Then spoke because captions were running.
“I never signed that.”
“I know.”
Claire’s jaw tightened.
“I signed consent for ventilation tubes.”
“That document has your signature.”
“I signed dozens of hospital pages that day.”
“Could one have included research?”
“No.”
The answer was immediate.
Then Claire stopped.
Facts.
She corrected herself.
“I do not remember signing any research authorization.”
Better.
Ellie nodded.
“I need copy.”
“I’ve already called Rebecca.”
Rebecca Chen had represented Claire through original investigation.
Still formidable.
Ellie shook head.
“No.”
Claire frowned.
“What?”
“I need my lawyer.”
A pause.
“You have Rebecca.”
“No.”
Another.
“She represents Westbrook.”
Claire went still.
“Ellie—”
“This company claims it owns rights to my medical data.”
Another.
“The data came partly through a company you control.”
Another.
“Our interests overlap.”
Another.
“They are not identical.”
Claire stared at daughter.
Then something in her face softened.
Not offended.
Proud perhaps.
But she wisely did not say.
“You’re right.”
Good.
“I’ll send you three names.”
“I’ll choose.”
“Yes.”
---
Ellie retained Maya Foster, a Boston attorney specializing in medical privacy, research consent, and technology licensing.
Forty-four.
Former hospital counsel.
No Westbrook ties.
Maya’s first question:
“Do you want your mother in the room?”
Ellie looked at Claire on video.
“Yes.”
“Does she understand I represent you?”
Claire said:
“Absolutely.”
Good.
Maya obtained the document from Sonora voluntarily because the conference incident was already spreading online.
The first page looked routine.
The signature page looked real.
Maya compared it to Claire’s archived surgical consent.
Then she stopped.
“These signatures are identical.”
Claire frowned.
“Because I sign similarly.”
“No.”
Maya zoomed both.
Every tremor.
Every ink break.
Every angle.
Pixel for pixel.
Identical.
“That does not happen with two handwritten signatures.”
Ellie leaned closer.
“It was copied.”
“Possibly.”
Facts.
Maya continued.
“Or the research document is a scanned composite using a signature from another page.”
Claire’s face hardened.
“Can we prove?”
“Forensic document examiner.”
“Yes.”
Then Ellie asked:
“Where did Sonora get archive?”
Maya checked acquisition disclosure.
Sonora purchased patents and “historic clinical development materials” from Crestwave Acoustics, the bankrupt company that manufactured the prototype found in Ellie’s ear.
But not directly.
The assets had passed through an intermediary seven years earlier.
A company called:
Rourke Technical Holdings LLC.
Claire went pale.
“You know that name?”
“Yes.”
“Who?”
“**Miles Rourke.**”
Former records director at Westbrook Medical Electronics.
A man interviewed during the original internal review.
A man who had told investigators he could find no surviving clinical-use archive connected to the prototype.
A man who now served as Sonora Neurotech’s chief strategy officer.
Ellie stared.
“So he said records were gone.”
Claire nodded slowly.
“Yes.”
“And seven years later he sold them.”
“That is what it appears.”
Maya raised one finger.
“Appears.”
Right.
Then her phone chimed.
Sonora’s counsel.
A formal proposal.
They offered to meet privately.
And attached one additional page from the alleged consent packet.
Maya opened.
Claire covered her mouth.
At bottom, beneath the research clause, was another signature.
Not hers.
GERALD WESTBROOK — FAMILY TRUSTEE / RESEARCH SPONSOR REPRESENTATIVE
Ellie became completely still.
Her uncle’s name had returned.
Not because he had come back into her life.
Because something he helped bury fifteen years earlier had apparently been sold, repackaged, and turned into a product.
May you like
And this time, the people using Ellie’s body as data were not hiding in an operating room.
They were standing beneath stage lights telling investors they had permission.
Related Stories
